{"canonical":"https://abierto.us/vendors/regeneron-pharmaceuticals-inc-n3f9mh7e6hd6","key":"N3F9MH7E6HD6","name":"REGENERON PHARMACEUTICALS INC","uei":"N3F9MH7E6HD6","city":"TARRYTOWN","state":"NY","awards":5,"obligated":"-329361115.48","notices_won":0,"top_agency_name":"Department of Veterans Affairs","top_naics":"325412","cage":"544P9","parent_name":"REGENERON PHARMACEUTICALS INC","also_known_as":[],"country":"USA","actions":22,"first_action":"2025-01-07","last_action":"2026-07-30","breakdowns":{"naics":[{"key":"325412","name":null,"awards":2,"obligated":"0.00"},{"key":"541711","name":null,"awards":3,"obligated":"-329361115.48"}],"places":[{"key":"NY","name":null,"awards":3,"obligated":"-329361115.48"}],"agencies":[{"key":"3600","name":"Department of Veterans Affairs","awards":2,"obligated":"0.00"},{"key":"7505","name":"Office of Assistant Secretary for Preparedness and Response","awards":3,"obligated":"-329361115.48"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":3,"obligated":"-329361115.48"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":4,"obligated":"-329023611.19"},{"key":"NOT COMPETED","name":null,"awards":1,"obligated":"-337504.29"}],"product_service_codes":[{"key":"6505","name":null,"awards":2,"obligated":"0.00"},{"key":"AN11","name":null,"awards":1,"obligated":"-337504.29"},{"key":"AN13","name":null,"awards":2,"obligated":"-329023611.19"}]},"awards_list":[{"award_key":"CONT_AWD_HHSO100201700016C_7505_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_HHSO100201700016C_7505_-NONE-_-NONE-/","piid":"HHSO100201700016C","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"N3F9MH7E6HD6","recipient_name":"REGENERON PHARMACEUTICALS INC","recipient_uei":"N3F9MH7E6HD6","recipient_cage":"544P9","recipient_city":"TARRYTOWN","recipient_state":"NY","sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2025-08-06","last_action_date":"2026-07-30","actions":2,"obligated":"2684548.91","current_total_value":"695741475.58","potential_total_value":"759103223.58","naics":"541711","psc":"AN13","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":2,"description":"NO COST MOD TO REVISE THE CONTRACT SECTIONS: ARTICLE B.4 AND F.4","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_36E79721A0023_3600","permalink":"https://www.usaspending.gov/award/CONT_IDV_36E79721A0023_3600/","piid":"36E79721A0023","parent_piid":"36F79721D0169","award_type":null,"vendor_key":"N3F9MH7E6HD6","recipient_name":"REGENERON PHARMACEUTICALS INC","recipient_uei":"N3F9MH7E6HD6","recipient_cage":"544P9","recipient_city":"TARRYTOWN","recipient_state":"NY","sub_name":"Department of Veterans Affairs","office_name":"NAC PHARMACEUTICALS (36E797)","office_key":"o-36E797","first_action_date":"2025-09-08","last_action_date":"2025-11-13","actions":2,"obligated":"0","current_total_value":null,"potential_total_value":"780000.00","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":1,"description":"EXERCISE OPTION YEAR 4","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_36F79721D0169_3600","permalink":"https://www.usaspending.gov/award/CONT_IDV_36F79721D0169_3600/","piid":"36F79721D0169","parent_piid":null,"award_type":null,"vendor_key":"N3F9MH7E6HD6","recipient_name":"REGENERON PHARMACEUTICALS INC","recipient_uei":"N3F9MH7E6HD6","recipient_cage":"544P9","recipient_city":"TARRYTOWN","recipient_state":"NY","sub_name":"Department of Veterans Affairs","office_name":"NAC FEDERAL SUPPLY SCHEDULE (36F797)","office_key":"o-36F797","first_action_date":"2025-01-07","last_action_date":"2026-06-26","actions":16,"obligated":"0","current_total_value":null,"potential_total_value":"3873189312.00","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":999,"description":"FSS","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HHSO100201600023C_7505_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_HHSO100201600023C_7505_-NONE-_-NONE-/","piid":"HHSO100201600023C","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"N3F9MH7E6HD6","recipient_name":"REGENERON PHARMACEUTICALS INC","recipient_uei":"N3F9MH7E6HD6","recipient_cage":"544P9","recipient_city":"TARRYTOWN","recipient_state":"NY","sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2026-03-19","last_action_date":"2026-03-19","actions":1,"obligated":"-337504.29","current_total_value":"8601628.71","potential_total_value":"10760114.71","naics":"541711","psc":"AN11","extent_competed":"NOT COMPETED","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"REGENERON ANTI-MERS ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HHSO100201700020C_7505_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_HHSO100201700020C_7505_-NONE-_-NONE-/","piid":"HHSO100201700020C","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"N3F9MH7E6HD6","recipient_name":"REGENERON PHARMACEUTICALS INC","recipient_uei":"N3F9MH7E6HD6","recipient_cage":"544P9","recipient_city":"TARRYTOWN","recipient_state":"NY","sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2025-08-08","last_action_date":"2025-08-08","actions":1,"obligated":"-331708160.10","current_total_value":"279610567.90","potential_total_value":"360378153.90","naics":"541711","psc":"AN13","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"E.O. RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING. DESCOPE MOD IAW WITH RTWS TO REMOVE UNUSED FUNDS FROM MULTIPLE CLINS RESULTING IN A DE-OBLIGATION OF $331,708,160.10 AND A REDUCTION IN TOTAL CONTRACT VALUE OF $331,708,160.10.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":5,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}